High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines

This publication has 21 references indexed in Scilit:

• Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock
  The Journal of Infectious Diseases, 1990
• The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
  The Journal of Experimental Medicine, 1989
• Treatment of Gram-Negative Septic Shock with Human IgG Antibody to Escherichia coli J5: A Prospective, Double-Blind, Randomized Trial
  The Journal of Infectious Diseases, 1988
• Multiple actions of interleukin 6 within a cytokine network
  Immunology Today, 1988
• Monocyte-Derived Human B-Cell Growth Factor Identified as Interferon-β ₂ (BSF-2, IL-6)
  Science, 1988
• Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts.
  The Journal of Experimental Medicine, 1987
• Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.
  The Journal of Experimental Medicine, 1987
• Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin
  Nature, 1986
• Induction of β2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation
  Cell, 1986
• Heterogeneity of poly(I).poly(C)-induced human fibroblast interferon mRNA species
  Nature, 1980